Molecular pathways of frontotemporal lobar degeneration.
Frontotemporal lobar degeneration (FTLD) is a neurodegenerative condition that predominantly affects behavior, social awareness, and language. It is characterized by extensive heterogeneity at the clinical, pathological, and genetic levels. Recognition of these levels of heterogeneity is important for proper disease management. The identification of progranulin and TDP-43 as key proteins in a significant proportion of FTLD patients has provided the impetus for a wealth of studies probing their role in neurodegeneration. This review highlights the most recent developments and future directions in this field and puts them in perspective of the novel insights into the neurodegenerative process, which have been gained from related disorders, e.g., the role of FUS in amyotrophic lateral sclerosis.
Sleegers
Kristel
K
Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Universiteitsplein 1, B-2610 Antwerpen, Belgium. kristel.sleegers@molgen.vib-ua.be
Cruts
Marc
M
Van Broeckhoven
Christine
C
D057174:Frontotemporal Lobar Degeneration / Q000209:etiology / Q000235:genetics* / Q000378:metabolism*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D009410:Nerve Degeneration / Q000209:etiology / Q000235:genetics* / Q000378:metabolism*; D010766:Phosphorylation / Q000235:genetics; D015398:Signal Transduction / Q000235:genetics*; D016875:tau Proteins / Q000235:genetics / Q000378:metabolism
D016875:tau Proteins